Company Filing History:
2 out of 21 
2 out of 1,345 
1 out of 12 Years Active: 2022-2025
Title: Exploring the Innovations of Inventor Jasdeep Mann
Introduction
Jasdeep Mann, an innovative inventor based in Seattle, WA, has made significant strides in the field of genome editing. With over two patents to his name, he is at the forefront of developing advanced techniques to edit genes that play critical roles in various diseases.
Latest Patents
Mann's latest patents focus on PD-1 homing endonuclease variants and their compositions and methods of use. These disclosures provide improved genome editing compositions aimed at editing the PD-1 gene. The innovations stand to enhance the prevention, treatment, or alleviation of symptoms associated with cancer, infectious diseases, autoimmune diseases, inflammatory diseases, and immunodeficiencies.
Career Highlights
Jasdeep Mann is currently associated with 2seventy Bio, Inc., a company known for its commitment to revolutionizing cell and gene therapies. His work at 2seventy Bio underscores his dedication to advancing therapeutic solutions that hold the promise of transforming patient outcomes through innovation in biotechnology.
Collaborations
Throughout his career, Mann has had the opportunity to collaborate with notable colleagues, including Joel Gay and Jordan Jarjour. These partnerships have enabled the sharing of diverse expertise and the fostering of innovative ideas, further enhancing the potential impact of their collective research efforts.
Conclusion
Jasdeep Mann exemplifies the spirit of innovation in biotechnology with his cutting-edge research and patent contributions. As the field of genome editing continues to evolve, his work is poised to play a crucial role in the development of therapeutic strategies that address some of the most challenging health issues of our time.